世界の化学療法誘発性悪心・嘔吐（CINV）治療薬市場2021-2026：アロキシ、ゾフランジェネリック、キトリルジェネリック、エメンド、アキンゼオ、SUSTOL、ロラピタント

◆英語タイトル：Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Market Growth 2021-2026
◆商品コード：LPI21MY9478
◆発行会社（リサーチ会社）：LP Information
◆発行日：2021年5月（※2024年版があります。お問い合わせください）
◆ページ数：132
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
◆産業分野：医薬品
◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,660 ⇒換算￥541,680	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,490 ⇒換算￥812,520	見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）	USD7,320 ⇒換算￥1,083,360	見積依頼/購入/質問フォーム

★LP Informationに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はLP Information社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。LP Information社の概要及び新刊レポートはこちらでご確認いただけます。

LPインフォメーション社の「化学療法誘発性悪心・嘔吐（CINV）治療薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、アロキシ、ゾフランジェネリック、キトリルジェネリック、エメンド、アキンゼオ、SUSTOL、ロラピタントなど、用途別には、急性CINV、遅延性CINVなどにセグメント区分してまとめました。化学療法誘発性悪心・嘔吐（CINV）治療薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。
・化学療法誘発性悪心・嘔吐（CINV）治療薬の世界市場概要（サマリー）
・化学療法誘発性悪心・嘔吐（CINV）治療薬の企業別販売量・売上
・化学療法誘発性悪心・嘔吐（CINV）治療薬の企業別市場シェア
・化学療法誘発性悪心・嘔吐（CINV）治療薬の世界市場規模 2016年-2021年：種類別（アロキシ、ゾフランジェネリック、キトリルジェネリック、エメンド、アキンゼオ、SUSTOL、ロラピタント）
・化学療法誘発性悪心・嘔吐（CINV）治療薬の世界市場規模 2016年-2021年：用途別（急性CINV、遅延性CINV）
・化学療法誘発性悪心・嘔吐（CINV）治療薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど）
・化学療法誘発性悪心・嘔吐（CINV）治療薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）
・化学療法誘発性悪心・嘔吐（CINV）治療薬のヨーロッパ市場規模（ドイツ、フランス、イギリス、イタリア、ロシアなど）
・化学療法誘発性悪心・嘔吐（CINV）治療薬の中東・アフリカ市場（エジプト、南アフリカ、トルコ、GCC諸国など）
・化学療法誘発性悪心・嘔吐（CINV）治療薬市場の成長要因・課題・動向
・化学療法誘発性悪心・嘔吐（CINV）治療薬の世界市場予測 2021年-2026年
・化学療法誘発性悪心・嘔吐（CINV）治療薬の南北アメリカ市場予測（アメリカ、カナダ、メキシコなど）
・化学療法誘発性悪心・嘔吐（CINV）治療薬のアジア市場予測（日本、中国、韓国、インド、東南アジアなど）
・化学療法誘発性悪心・嘔吐（CINV）治療薬のヨーロッパ市場予測（ドイツ、フランス、イギリス、イタリア、ロシアなど）
・化学療法誘発性悪心・嘔吐（CINV）治療薬の中東・アフリカ市場予測（エジプト、南アフリカ、トルコ、GCC諸国など）
・化学療法誘発性悪心・嘔吐（CINV）治療薬の世界市場予測：種類別（アロキシ、ゾフランジェネリック、キトリルジェネリック、エメンド、アキンゼオ、SUSTOL、ロラピタント）
・化学療法誘発性悪心・嘔吐（CINV）治療薬の世界市場予測：用途別（急性CINV、遅延性CINV）
・主要企業分析

【レポートの概要】

According to this latest study, the 2020 growth of Chemotherapy Induced Nausea and Vomiting （CINV） Drugs will have significant change from previous year. By the most conservative estimates of global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Chemotherapy Induced Nausea and Vomiting （CINV） Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Chemotherapy Induced Nausea and Vomiting （CINV） Drugs market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Aloxi
Zofran Generic
Kytril Generic
Emend
Akynzeo
SUSTOL
Rolapitant

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Acute CINV
Delayed CINV

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
GlaxoSmithKline
Helsinn
Heron Therapeutics
Merck
Tesaro

【レポートの目次】

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Consumption 2016-2026
2.1.2 Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Consumption CAGR by Region
2.2 Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Segment by Type
2.2.1 Aloxi
2.2.2 Zofran Generic
2.2.3 Kytril Generic
2.2.4 Emend
2.2.5 Akynzeo
2.2.6 SUSTOL
2.2.7 Rolapitant
2.3 Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Type
2.3.1 Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Type (2016-2021)
2.3.2 Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue and Market Share by Type (2016-2021)
2.3.3 Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sale Price by Type (2016-2021)
2.4 Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Segment by Application
2.4.1 Acute CINV
2.4.2 Delayed CINV
2.5 Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Application
2.5.1 Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sale Market Share by Application (2016-2021)
2.5.2 Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue and Market Share by Application (2016-2021)
2.5.3 Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sale Price by Application (2016-2021)

3 Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs by Company
3.1 Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Company
3.1.1 Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Company (2019-2021)
3.1.2 Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Company (2019-2021)
3.2 Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Market Share by Company
3.2.1 Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue by Company (2019-2021)
3.2.2 Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Market Share by Company (2019-2021)
3.3 Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sale Price by Company
3.4 Global Manufacturers Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Product Location Distribution
3.4.2 Players Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Chemotherapy Induced Nausea and Vomiting （CINV） Drugs by Region
4.1 Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs by Region
4.1.1 Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Region
4.1.2 Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue by Region
4.2 Americas Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Growth
4.3 APAC Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Growth
4.4 Europe Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Growth
4.5 Middle East & Africa Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Growth

5 Americas
5.1 Americas Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Country
5.1.1 Americas Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Country (2016-2021)
5.1.2 Americas Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue by Country (2016-2021)
5.2 Americas Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Type
5.3 Americas Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Region
6.1.1 APAC Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Region (2016-2021)
6.1.2 APAC Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue by Region (2016-2021)
6.2 APAC Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Type
6.3 APAC Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Chemotherapy Induced Nausea and Vomiting （CINV） Drugs by Country
7.1.1 Europe Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Country (2016-2021)
7.1.2 Europe Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue by Country (2016-2021)
7.2 Europe Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Type
7.3 Europe Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Chemotherapy Induced Nausea and Vomiting （CINV） Drugs by Country
8.1.1 Middle East & Africa Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Country (2016-2021)
8.1.2 Middle East & Africa Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue by Country (2016-2021)
8.2 Middle East & Africa Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Type
8.3 Middle East & Africa Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Distributors
10.3 Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Customer

11 Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Market Forecast
11.1 Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Forecast by Region
11.1.1 Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Forecast by Regions (2021-2026)
11.2.2 Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Countries
11.3 APAC Forecast by Region
11.4 Europe Forecast by Countries
11.5 Middle East & Africa Forecast by Countries
11.6 Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Forecast by Type
11.7 Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Forecast by Application

12 Key Players Analysis
12.1 GlaxoSmithKline
12.1.1 GlaxoSmithKline GlaxoSmithKline Company Information
12.1.2 GlaxoSmithKline Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Product Offered
12.1.3 GlaxoSmithKline Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 GlaxoSmithKline Main Business Overview
12.1.5 GlaxoSmithKline Latest Developments
12.2 Helsinn
12.2.1 Helsinn Company Information
12.2.2 Helsinn Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Product Offered
12.2.3 Helsinn Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Helsinn Main Business Overview
12.2.5 Helsinn Latest Developments
12.3 Heron Therapeutics
12.3.1 Heron Therapeutics Company Information
12.3.2 Heron Therapeutics Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Product Offered
12.3.3 Heron Therapeutics Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Heron Therapeutics Main Business Overview
12.3.5 Heron Therapeutics Latest Developments
12.4 Merck
12.4.1 Merck Company Information
12.4.2 Merck Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Product Offered
12.4.3 Merck Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Merck Main Business Overview
12.4.5 Merck Latest Developments
12.5 Tesaro
12.5.1 Tesaro Company Information
12.5.2 Tesaro Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Product Offered
12.5.3 Tesaro Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Tesaro Main Business Overview
12.5.5 Tesaro Latest Developments
…

13 Research Findings and Conclusion

List of Tables
Table 1. Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Aloxi
Table 3. Major Players of Zofran Generic
Table 4. Major Players of Kytril Generic
Table 5. Major Players of Emend
Table 6. Major Players of Akynzeo
Table 7. Major Players of SUSTOL
Table 8. Major Players of Rolapitant
Table 9. Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Type (2016-2021) & (K Pcs)
Table 10. Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Type (2016-2021)
Table 11. Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue by Type (2016-2021) & ($ million)
Table 12. Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Market Share by Type (2016-2021)
Table 13. Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sale Price by Type (2016-2021)
Table 14. Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Application (2016-2021) & (K Pcs)
Table 15. Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Application (2016-2021)
Table 16. Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Value by Application (2016-2021)
Table 17. Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Market Share by Application (2016-2021)
Table 18. Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sale Price by Application (2016-2021)
Table 19. Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Company (2019-2021) & (K Pcs)
Table 20. Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Company (2019-2021)
Table 21. Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue by Company (2019-2021) ($ Millions)
Table 22. Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Market Share by Company (2019-2021)
Table 23. Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sale Price by Company (2019-2021)
Table 24. Key Manufacturers Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Producing Area Distribution and Sales Area
Table 25. Players Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Products Offered
Table 26. Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 27. New Products and Potential Entrants
Table 28. Mergers & Acquisitions, Expansion
Table 29. Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Region (2016-2021) (K Pcs)
Table 30. Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Region (2016-2021)
Table 31. Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue by Region (2016-2021) & ($ Millions)
Table 32. Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Market Share by Region (2016-2021)
Table 33. Americas Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Country (2016-2021) & (K Pcs)
Table 34. Americas Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Country (2016-2021)
Table 35. Americas Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 36. Americas Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Market Share by Country (2016-2021)
Table 37. Americas Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Type (2016-2021) & (K Pcs)
Table 38. Americas Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Type (2016-2021)
Table 39. Americas Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Application (2016-2021) & (K Pcs)
Table 40. Americas Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Application (2016-2021)
Table 41. APAC Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Region (2016-2021) & (K Pcs)
Table 42. APAC Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Region (2016-2021)
Table 43. APAC Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue by Region (2016-2021) & ($ Millions)
Table 44. APAC Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Market Share by Region (2016-2021)
Table 45. APAC Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Type (2016-2021) & (K Pcs)
Table 46. APAC Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Type (2016-2021)
Table 47. APAC Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Application (2016-2021) & (K Pcs)
Table 48. APAC Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Application (2016-2021)
Table 49. Europe Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Country (2016-2021) & (K Pcs)
Table 50. Europe Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Country (2016-2021)
Table 51. Europe Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 52. Europe Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Market Share by Country (2016-2021)
Table 53. Europe Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Type (2016-2021) & (K Pcs)
Table 54. Europe Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Type (2016-2021)
Table 55. Europe Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Application (2016-2021) & (K Pcs)
Table 56. Europe Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Application (2016-2021)
Table 57. Middle East & Africa Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Country (2016-2021) & (K Pcs)
Table 58. Middle East & Africa Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Country (2016-2021)
Table 59. Middle East & Africa Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 60. Middle East & Africa Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Market Share by Country (2016-2021)
Table 61. Middle East & Africa Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Type (2016-2021) & (K Pcs)
Table 62. Middle East & Africa Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Type (2016-2021)
Table 63. Middle East & Africa Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Application (2016-2021) & (K Pcs)
Table 64. Middle East & Africa Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Application (2016-2021)
Table 65. Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Forecast by Type (2021-2026) & (K Pcs)
Table 66. Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share Forecast by Type (2021-2026)
Table 67. Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 68. Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Market Share Forecast by Type (2021-2026)
Table 69. Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Forecast by Application (2021-2026) & (K Pcs)
Table 70. Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share Forecast by Application (2021-2026)
Table 71. Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 72. Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Market Share Forecast by Application (2021-2026)
Table 73. GlaxoSmithKline Basic Information, Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Manufacturing Base, Sales Area and Its Competitors
Table 74. GlaxoSmithKline Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Product Offered
Table 75. GlaxoSmithKline Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 76. GlaxoSmithKline Main Business
Table 77. GlaxoSmithKline Latest Developments
Table 78. Helsinn Basic Information, Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Manufacturing Base, Sales Area and Its Competitors
Table 79. Helsinn Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Product Offered
Table 80. Helsinn Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 81. Helsinn Main Business
Table 82. Helsinn Latest Developments
Table 83. Heron Therapeutics Basic Information, Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Manufacturing Base, Sales Area and Its Competitors
Table 84. Heron Therapeutics Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Product Offered
Table 85. Heron Therapeutics Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 86. Heron Therapeutics Main Business
Table 87. Heron Therapeutics Latest Developments
Table 88. Merck Basic Information, Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Manufacturing Base, Sales Area and Its Competitors
Table 89. Merck Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Product Offered
Table 90. Merck Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 91. Merck Main Business
Table 92. Merck Latest Developments
Table 93. Tesaro Basic Information, Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Manufacturing Base, Sales Area and Its Competitors
Table 94. Tesaro Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Product Offered
Table 95. Tesaro Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 96. Tesaro Main Business
Table 97. Tesaro Latest Developments
List of Figures
Figure 1. Picture of Chemotherapy Induced Nausea and Vomiting （CINV） Drugs
Figure 2. Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Growth Rate 2016-2026 (K Pcs)
Figure 7. Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Aloxi
Figure 10. Product Picture of Zofran Generic
Figure 11. Product Picture of Kytril Generic
Figure 12. Product Picture of Emend
Figure 13. Product Picture of Akynzeo
Figure 14. Product Picture of SUSTOL
Figure 15. Product Picture of Rolapitant
Figure 16. Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Type in 2020
Figure 17. Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Market Share by Type (2016-2021)
Figure 18. Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Consumed in Acute CINV
Figure 19. Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Market: Acute CINV (2016-2021) & (K Pcs)
Figure 20. Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Consumed in Delayed CINV
Figure 21. Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Market: Delayed CINV (2016-2021) & (K Pcs)
Figure 22. Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Application (2016-2021)
Figure 23. Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Market Share by Application in 2020
Figure 24. Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Market by Company in 2020 ($ Million)
Figure 25. Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Market Share by Company in 2020
Figure 26. Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Regions (2016-2021)
Figure 27. Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Market Share by Region in 2020
Figure 28. Americas Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales 2016-2021 (K Pcs)
Figure 29. Americas Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue 2016-2021 ($ Millions)
Figure 30. APAC Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales 2016-2021 (K Pcs)
Figure 31. APAC Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue 2016-2021 ($ Millions)
Figure 32. Europe Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales 2016-2021 (K Pcs)
Figure 33. Europe Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue 2016-2021 ($ Millions)
Figure 34. Middle East & Africa Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales 2016-2021 (K Pcs)
Figure 35. Middle East & Africa Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue 2016-2021 ($ Millions)
Figure 36. Americas Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Country in 2020
Figure 37. Americas Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Market Share by Country in 2020
Figure 38. Americas Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Type in 2020
Figure 39. Americas Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Application in 2020
Figure 40. United States Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 41. Canada Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 42. Mexico Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 43. Brazil Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 44. APAC Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Region in 2020
Figure 45. APAC Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Market Share by Regions in 2020
Figure 46. APAC Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Type in 2020
Figure 47. APAC Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Application in 2020
Figure 48. China Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 49. Japan Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 50. Korea Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 51. Southeast Asia Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 52. India Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 53. Australia Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 54. Europe Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Country in 2020
Figure 55. Europe Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Market Share by Country in 2020
Figure 56. Europe Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Type in 2020
Figure 57. Europe Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Application in 2020
Figure 58. Germany Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 59. France Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 60. UK Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 61. Italy Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 62. Russia Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 63. Middle East & Africa Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Country in 2020
Figure 64. Middle East & Africa Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Market Share by Country in 2020
Figure 65. Middle East & Africa Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Type in 2020
Figure 66. Middle East & Africa Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Sales Market Share by Application in 2020
Figure 67. Egypt Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 68. South Africa Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 69. Israel Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 70. Turkey Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 71. GCC Country Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 72. Channels of Distribution
Figure 73. Distributors Profiles

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の化学療法誘発性悪心・嘔吐（CINV）治療薬市場2021-2026：アロキシ、ゾフランジェネリック、キトリルジェネリック、エメンド、アキンゼオ、SUSTOL、ロラピタント(Global Chemotherapy Induced Nausea and Vomiting （CINV） Drugs Market Growth 2021-2026)]についてメールでお問い合わせはこちらでお願いします。

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 GlobalResearch.jp